Victory Capital Management
ORKA

Victory Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Victory Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Buy
124,278
+119,600
+2,557% +$7.97M 0.01% 1061
2026
Q1 		$229K Buy
+4,678
New +$163K ﹤0.01% 2174
2020
Q2 		– Sell
-21
Closed -$1K – 3331
2020
Q1 		$1K Buy
+21
New +$1.14K ﹤0.01% 3658
2019
Q4 		– Sell
-20
Closed -$1K – 3321
2019
Q3 		$1K Buy
+20
New +$1.47K ﹤0.01% 3730

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Victory Capital Management's ORKA Position: Q2 2026 in Review

Victory Capital Management increased its Oruka Therapeutics (ORKA) stake by 2,557% in Q2 2026, buying an estimated $7.97M and bringing the position to 124,278 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #1061.

Victory Capital Management first reported a position in ORKA in Q3 2019 and has held it in 4 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Victory Capital Management held 124,278 shares of Oruka Therapeutics worth $11.8M as of Q2 2026.
  • Victory Capital Management bought 119,600 Oruka Therapeutics shares in Q2 2026, an estimated $7.97M.
  • Oruka Therapeutics made up 0.01% of Victory Capital Management's portfolio in Q2 2026, its #1061 holding.
  • Victory Capital Management first reported a position in Oruka Therapeutics in Q3 2019 and has held it in 4 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.